Abstract-NO is known to induce expression of heme oxygenase-1, an antioxidant enzyme in blood vessels. We tested whether NO might modulate the endothelial NADPH oxidase function via heme oxygenase-1. In human microvascular endothelial cells, the NO donor DETA-NONOate (0.1 to 1 mmol/L) strongly induced expression of heme oxygenase-1 but not Cu/Zn superoxide dismutase. This was associated with a reduction of the superoxide-generating capacity of NADPH oxidase, an effect that depended on de novo gene transcription and heme oxygenase-1 activity. Activation of NADPH oxidase by tumor necrosis factor (TNF) ␣ increased generation of reactive oxygen species. DETA-NONOate alone had little effect on TNF-stimulated reactive oxygen species, but it enhanced the TNF response when: (1) heme oxygenase-1 expression was blocked with specific small-interfering RNA; (2) heme oxygenase-1 activity was blocked by zinc-protoporphyrin; or (3) NADPH oxidase activity was blocked by diphenyleneiodonium. Moreover, the heme oxygenase-1 end product bilirubin directly inhibited fully functional NADPH oxidase and seemed to interrupt the assembly and activation of the oxidase. In conclusion, NO may modulate superoxide production by NADPH oxidase in human vascular endothelial cells, at least partly by inducing heme oxygenase-1. Our results indicate that suppression of NADPH oxidase-dependent reactive oxygen species formation may represent a novel mechanism underlying the cardiovascular protective actions of heme oxygenase-1 and bilirubin. Key Words: bilirubin Ⅲ endothelium Ⅲ heme oxygenase-1 Ⅲ NADPH oxidase Ⅲ nitric oxide Ⅲ oxidant stress N itric oxide is crucial for maintaining normal vascular function, and inactivation of NO by excessive production of reactive oxygen species (ROS) is implicated in several cardiovascular diseases. 1,2 There is increasing evidence that NADPH oxidase expressed in endothelial cells (ECs) and vascular smooth muscle cells (VSMCs) is a major source of superoxide. 3 Five isoforms of the Nox subunit of NADPH oxidase have been identified (named Nox1 to Nox5), of which Nox1, Nox2, and Nox4 are found in vascular tissues. 4 -6 Increased NADPH oxidase activation is associated with conditions such as endothelial dysfunction, intimal hyperplasia, atherosclerosis, and hypertension 7 and has been linked to impairment of endothelial NO function in patients with coronary artery disease. 8 Recently, we found that treatment of human microvascular ECs (HMECs) with NO donors inhibited the superoxidegenerating capacity of NADPH oxidase, which may involve S-nitrosylation of the p47phox subunit. 9 In addition, previous studies have revealed that exposure of ECs to exogenous NO induces Nrf2-dependent expression of heme oxygenase-1 (HO-1), 10 the rate-limiting enzyme in heme degradation. Several lines of evidence have indicated that induction of HO-1 has remarkable antioxidant effects, because: (1) bilirubin is a free radical scavenger and has chain-breaking antioxidant activity which may prevent lipid peroxidation 11 ;(2) HO-1 expression ...